Added ReadMe.md
Browse files
README.md
CHANGED
@@ -1,199 +1,62 @@
|
|
1 |
-
|
2 |
-
library_name: transformers
|
3 |
-
tags: []
|
4 |
-
---
|
5 |
-
|
6 |
-
# Model Card for Model ID
|
7 |
-
|
8 |
-
<!-- Provide a quick summary of what the model is/does. -->
|
9 |
-
|
10 |
-
|
11 |
-
|
12 |
-
## Model Details
|
13 |
-
|
14 |
-
### Model Description
|
15 |
-
|
16 |
-
<!-- Provide a longer summary of what this model is. -->
|
17 |
-
|
18 |
-
This is the model card of a π€ transformers model that has been pushed on the Hub. This model card has been automatically generated.
|
19 |
-
|
20 |
-
- **Developed by:** [More Information Needed]
|
21 |
-
- **Funded by [optional]:** [More Information Needed]
|
22 |
-
- **Shared by [optional]:** [More Information Needed]
|
23 |
-
- **Model type:** [More Information Needed]
|
24 |
-
- **Language(s) (NLP):** [More Information Needed]
|
25 |
-
- **License:** [More Information Needed]
|
26 |
-
- **Finetuned from model [optional]:** [More Information Needed]
|
27 |
-
|
28 |
-
### Model Sources [optional]
|
29 |
-
|
30 |
-
<!-- Provide the basic links for the model. -->
|
31 |
-
|
32 |
-
- **Repository:** [More Information Needed]
|
33 |
-
- **Paper [optional]:** [More Information Needed]
|
34 |
-
- **Demo [optional]:** [More Information Needed]
|
35 |
-
|
36 |
-
## Uses
|
37 |
-
|
38 |
-
<!-- Address questions around how the model is intended to be used, including the foreseeable users of the model and those affected by the model. -->
|
39 |
-
|
40 |
-
### Direct Use
|
41 |
-
|
42 |
-
<!-- This section is for the model use without fine-tuning or plugging into a larger ecosystem/app. -->
|
43 |
-
|
44 |
-
[More Information Needed]
|
45 |
-
|
46 |
-
### Downstream Use [optional]
|
47 |
-
|
48 |
-
<!-- This section is for the model use when fine-tuned for a task, or when plugged into a larger ecosystem/app -->
|
49 |
-
|
50 |
-
[More Information Needed]
|
51 |
-
|
52 |
-
### Out-of-Scope Use
|
53 |
-
|
54 |
-
<!-- This section addresses misuse, malicious use, and uses that the model will not work well for. -->
|
55 |
-
|
56 |
-
[More Information Needed]
|
57 |
-
|
58 |
-
## Bias, Risks, and Limitations
|
59 |
-
|
60 |
-
<!-- This section is meant to convey both technical and sociotechnical limitations. -->
|
61 |
-
|
62 |
-
[More Information Needed]
|
63 |
-
|
64 |
-
### Recommendations
|
65 |
-
|
66 |
-
<!-- This section is meant to convey recommendations with respect to the bias, risk, and technical limitations. -->
|
67 |
-
|
68 |
-
Users (both direct and downstream) should be made aware of the risks, biases and limitations of the model. More information needed for further recommendations.
|
69 |
-
|
70 |
-
## How to Get Started with the Model
|
71 |
-
|
72 |
-
Use the code below to get started with the model.
|
73 |
-
|
74 |
-
[More Information Needed]
|
75 |
-
|
76 |
-
## Training Details
|
77 |
-
|
78 |
-
### Training Data
|
79 |
-
|
80 |
-
<!-- This should link to a Dataset Card, perhaps with a short stub of information on what the training data is all about as well as documentation related to data pre-processing or additional filtering. -->
|
81 |
-
|
82 |
-
[More Information Needed]
|
83 |
-
|
84 |
-
### Training Procedure
|
85 |
|
86 |
-
|
87 |
|
88 |
-
|
89 |
|
90 |
-
|
91 |
-
|
92 |
-
|
93 |
-
#### Training Hyperparameters
|
94 |
-
|
95 |
-
- **Training regime:** [More Information Needed] <!--fp32, fp16 mixed precision, bf16 mixed precision, bf16 non-mixed precision, fp16 non-mixed precision, fp8 mixed precision -->
|
96 |
-
|
97 |
-
#### Speeds, Sizes, Times [optional]
|
98 |
-
|
99 |
-
<!-- This section provides information about throughput, start/end time, checkpoint size if relevant, etc. -->
|
100 |
-
|
101 |
-
[More Information Needed]
|
102 |
-
|
103 |
-
## Evaluation
|
104 |
-
|
105 |
-
<!-- This section describes the evaluation protocols and provides the results. -->
|
106 |
-
|
107 |
-
### Testing Data, Factors & Metrics
|
108 |
-
|
109 |
-
#### Testing Data
|
110 |
-
|
111 |
-
<!-- This should link to a Dataset Card if possible. -->
|
112 |
-
|
113 |
-
[More Information Needed]
|
114 |
-
|
115 |
-
#### Factors
|
116 |
-
|
117 |
-
<!-- These are the things the evaluation is disaggregating by, e.g., subpopulations or domains. -->
|
118 |
-
|
119 |
-
[More Information Needed]
|
120 |
-
|
121 |
-
#### Metrics
|
122 |
-
|
123 |
-
<!-- These are the evaluation metrics being used, ideally with a description of why. -->
|
124 |
-
|
125 |
-
[More Information Needed]
|
126 |
-
|
127 |
-
### Results
|
128 |
-
|
129 |
-
[More Information Needed]
|
130 |
-
|
131 |
-
#### Summary
|
132 |
-
|
133 |
-
|
134 |
-
|
135 |
-
## Model Examination [optional]
|
136 |
-
|
137 |
-
<!-- Relevant interpretability work for the model goes here -->
|
138 |
-
|
139 |
-
[More Information Needed]
|
140 |
-
|
141 |
-
## Environmental Impact
|
142 |
-
|
143 |
-
<!-- Total emissions (in grams of CO2eq) and additional considerations, such as electricity usage, go here. Edit the suggested text below accordingly -->
|
144 |
-
|
145 |
-
Carbon emissions can be estimated using the [Machine Learning Impact calculator](https://mlco2.github.io/impact#compute) presented in [Lacoste et al. (2019)](https://arxiv.org/abs/1910.09700).
|
146 |
-
|
147 |
-
- **Hardware Type:** [More Information Needed]
|
148 |
-
- **Hours used:** [More Information Needed]
|
149 |
-
- **Cloud Provider:** [More Information Needed]
|
150 |
-
- **Compute Region:** [More Information Needed]
|
151 |
-
- **Carbon Emitted:** [More Information Needed]
|
152 |
-
|
153 |
-
## Technical Specifications [optional]
|
154 |
-
|
155 |
-
### Model Architecture and Objective
|
156 |
-
|
157 |
-
[More Information Needed]
|
158 |
-
|
159 |
-
### Compute Infrastructure
|
160 |
-
|
161 |
-
[More Information Needed]
|
162 |
-
|
163 |
-
#### Hardware
|
164 |
|
165 |
-
|
|
|
|
|
|
|
|
|
|
|
|
|
166 |
|
167 |
-
|
168 |
|
169 |
-
|
|
|
|
|
|
|
|
|
170 |
|
171 |
-
|
172 |
|
173 |
-
|
174 |
|
175 |
-
|
176 |
|
177 |
-
|
178 |
|
179 |
-
|
|
|
180 |
|
181 |
-
|
|
|
182 |
|
183 |
-
|
|
|
|
|
|
|
|
|
|
|
184 |
|
185 |
-
|
186 |
|
187 |
-
|
|
|
|
|
188 |
|
189 |
-
|
190 |
|
191 |
-
|
192 |
|
193 |
-
|
194 |
|
195 |
-
|
196 |
|
197 |
-
|
198 |
|
199 |
-
|
|
|
1 |
+
Hereβs a sample README.md file for your Hugging Face model repository:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2 |
|
3 |
+
# π€ [Phi-3-Clinical]
|
4 |
|
5 |
+
Welcome to the repository for Phi-3-Clinical, a fine-tuned model designed to empower medical researchers and developers in the Bio-Pharma domain. This model has been meticulously trained on clinical trial datasets from the U.S. government to deliver high-quality insights and facilitate research and development in healthcare and pharmaceutical innovation. This model is currently being actively updated and improved as part of my ongoing research and work in Retrieval-Augmented Generation (RAG).
|
6 |
|
7 |
+
---
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
8 |
|
9 |
+
## π Key Features
|
10 |
+
- **Fine-Tuned on**: [Dataset(s) name]
|
11 |
+
- **Primary Use Case(s)**: [Summarization, Question Answering, etc.]
|
12 |
+
- **Updates in Progress**:
|
13 |
+
- Optimizing for better accuracy with RAG workflows.
|
14 |
+
- Incorporating new datasets and training strategies.
|
15 |
+
- Fine-tuning with community feedback.
|
16 |
|
17 |
+
---
|
18 |
|
19 |
+
## π
What's Next?
|
20 |
+
I am actively working on:
|
21 |
+
1. Integrating this model into a RAG pipeline for enhanced retrieval-augmented tasks.
|
22 |
+
2. Regular updates to improve performance and reduce inference time.
|
23 |
+
3. Expanding support for [languages/domains/etc.].
|
24 |
|
25 |
+
Stay tuned for updates and improvements in the coming weeks!
|
26 |
|
27 |
+
---
|
28 |
|
29 |
+
## π οΈ How to Use
|
30 |
|
31 |
+
Here's a quick example of how you can use this model:
|
32 |
|
33 |
+
```python
|
34 |
+
from transformers import pipeline
|
35 |
|
36 |
+
# Load the model
|
37 |
+
model = pipeline("task_name", model="hackint0sh/phi-3-clinical")
|
38 |
|
39 |
+
# Example usage
|
40 |
+
input_text = "Your input here"
|
41 |
+
output = model(input_text)
|
42 |
+
print(output)
|
43 |
+
```
|
44 |
+
Replace task_name with the appropriate task (e.g., "text-classification", "question-answering", "Clinical Trial Format").
|
45 |
|
46 |
+
πββοΈ Need Help?
|
47 |
|
48 |
+
Iβm here to help! If you have any questions, suggestions, or encounter any issues while using the model, feel free to:
|
49 |
+
β’ Open an Issue on this repository.
|
50 |
+
β’ DM me directly on Hugging Face.
|
51 |
|
52 |
+
Iβm always happy to collaborate and improve this model further based on your feedback. π
|
53 |
|
54 |
+
π Contributing
|
55 |
|
56 |
+
Contributions are welcome! If you have ideas for improvements or want to contribute, feel free to fork this repository and open a pull request.
|
57 |
|
58 |
+
π License
|
59 |
|
60 |
+
This model is released under the MIT license. See the LICENSE file for more details.
|
61 |
|
62 |
+
Thank you for your interest in Phi-3-Clinical! Your support and feedback help make this model better for everyone. β€οΈ
|